Citations for
1IL19, IL24
Expression of interleukin (IL)-19 and IL-24 in inflammatory bowel disease patients: a cross-sectional study.
Fonseca-Camarillo G, Furuzawa-Carballeda J, Granados J, Yamamoto-Furusho JK.
Clin Exp Immunol 177(1):64-75. doi: 10.1111/cei.12285. 2014
2IL24, SIGMAR1
Sigma 1 Receptor plays a prominent role in IL-24-induced cancer-specific apoptosis.
Do W, Herrera C, Mighty J, Shumskaya M, Redenti SM, Sauane M.
Biochem Biophys Res Commun 439(2):215-20. doi: 10.1016/j.bbrc.2013.08.057. Epub 2013 Aug 26. 2013
3IL24
Potential implication of IL-24 in lymphangiogenesis of human breast cancer.
Frewer NC, Ye L, Sun PH, Owen S, Ji K, Frewer KA, Hargest R, Jiang WG.
Int J Mol Med 31(5):1097-104. doi: 10.3892/ijmm.2013.1319. Epub 2013 Mar 27. 2013
4IL24
Interleukin-24 suppresses the growth of vascular smooth muscle cells by inhibiting H(2)O(2)-induced reactive oxygen species production.
Lee KM, Kang HA, Park M, Lee HY, Song MJ, Ko K, Oh JW, Kang HS.
Pharmacology 90(5-6):332-41. doi: 10.1159/000343242. Epub 2012 Oct 9. 2012
5IL24
Critical role of lysine 123 in the ubiquitin-mediated degradation of MDA-7/IL-24.
Tian H, Li L, Zhang B, Di J, Chen F, Li H, Liu J, Pei D, Zheng J.
J Interferon Cytokine Res 32(12):575-82. doi: 10.1089/jir.2012.0055. Epub 2012 Oct 18. 2012
6IL24
Interleukin-24 attenuates β-glycerophosphate-induced calcification of vascular smooth muscle cells by inhibiting apoptosis, the expression of calcification and osteoblastic markers, and the Wnt/β-catenin pathway.
Lee KM, Kang HA, Park M, Lee HY, Choi HR, Yun CH, Oh JW, Kang HS.
Biochem Biophys Res Commun 428(1):50-5. doi: 10.1016/j.bbrc.2012.09.145. Epub 2012 Oct 11. 2012
7IL24
Splice variants of mda-7/IL-24 differentially affect survival and induce apoptosis in U2OS cells.
Whitaker EL, Filippov V, Filippova M, Guerrero-Juarez CF, Duerksen-Hughes PJ.
Cytokine 56(2):272-81. doi: 10.1016/j.cyto.2011.07.020. Epub 2011 Aug 16. 2011
8IL24, JUN, STAT6
Stat6 and c-Jun mediate Th2 cell-specific IL-24 gene expression.
Sahoo A, Lee CG, Jash A, Son JS, Kim G, Kwon HK, So JS, Im SH.
J Immunol 186(7):4098-109. doi: 10.4049/jimmunol.1002620. Epub 2011 Feb 25. 2011
9IL24
IL-24 is expressed during wound repair and inhibits TGFalpha-induced migration and proliferation of keratinocytes.
Poindexter NJ, Williams RR, Powis G, Jen E, Caudle AS, Chada S, Grimm EA.
Exp Dermatol 19(8):714-22. doi: 10.1111/j.1600-0625.2010.01077.x. 2010
10IL24
The p38 MAPK regulates IL-24 expression by stabilization of the 3' UTR of IL-24 mRNA.
Otkjaer K, Holtmann H, Kragstrup TW, Paludan SR, Johansen C, Gaestel M, Kragballe K, Iversen L.
PLoS One 5(1):e8671. doi: 10.1371/journal.pone.0008671. 2010
11IL24
Interleukin-24 inhibits the plasma cell differentiation program in human germinal center B cells.
Maarof G, Bouchet-Delbos L, Gary-Gouy H, Durand-Gasselin I, Krzysiek R, Dalloul A.
Blood 115(9):1718-26. doi: 10.1182/blood-2009-05-220251. Epub 2009 Nov 24. 2010
12IL24
Loss of novel mda-7 splice variant (mda-7s) expression is associated with metastatic melanoma.
Allen M, Pratscher B, Roka F, Krepler C, Wacheck V, Schofer C, Pehamberger H, Muller M, Lucas T.
J Invest Dermatol 123(3):583-8. 2004
13IL24
Loss of MDA-7 expression with progression of melanoma.
Ellerhorst JA, Prieto VG, Ekmekcioglu S, Broemeling L, Yekell S, Chada S, Grimm EA.
J Clin Oncol 20(4):1069-74. 2002
14IL24
The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.
Caudell EG, Mumm JB, Poindexter N, Ekmekcioglu S, Mhashilkar AM, Yang XH, Retter MW, Hill P, Chada S, Grimm EA.
J Immunol 168(12):6041-6. 2002
15IL24
Melanoma differentiation associated gene-7 (mda-7): a novel anti-tumor gene for cancer gene therapy.
Mhashilkar AM, Schrock RD, Hindi M, Liao J, Sieger K, Kourouma F, Zou-Yang XH, Onishi E, Takh O, Vedvick TS, Fanger G, Stewart L, Watson GJ, Snary D, Fisher PB, Saeki T, Roth JA, Ramesh R, Chada S.
Mol Med 7(4):271-82. 2001
16IL24
Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY, Madireddi MT, Gopalkrishnan RV, Leszczyniecka M, Su Z, Lebedeva IV, Kang D, Jiang H, Lin JJ, Alexandre D, Chen Y, Vozhilla N, Mei MX, Christiansen KA, Sivo F, Goldstein NI, Mhashilkar AB, Chada S, Huberman E, Pestka S, Fisher PB.
Oncogene 20(48):7051-63. 2001
17GFND1, IL24, MAPKAPK2, SRP72
Molecular cloning of the critical region for glomerulopathy with fibronectin deposits (GFND) and evaluation of candidate genes.
Vollmer M, Kremer M, Ruf R, Miot S, Nothwang HG, Wirth J, Otto E, Krapf R, Hildebrandt F.
Genomics 68(2):127-35. 2000
18IL24
The cancer growth suppressor gene mda-7 selectively induces apoptosis in human breast cancer cells and inhibits tumor growth in nude mice.
Su ZZ, Madireddi MT, Lin JJ, Young CS, Kitada S, Reed JC, Goldstein NI, Fisher PB.
Proc Natl Acad Sci U S A 95(24):14400-5. 1998
19IL24
The melanoma differentiation associated gene mda-7 suppresses cancer cell growth.
Jiang H, Su ZZ, Lin JJ, Goldstein NI, Young CS, Fisher PB.
Proc Natl Acad Sci U S A 93(17):9160-5. 1996
20IL24
Subtraction hybridization identifies a novel melanoma differentiation associated gene, mda-7, modulated during human melanoma differentiation, growth and progression.
Jiang H, Lin JJ, Su ZZ, Goldstein NI, Fisher PB.
Oncogene 11(12):2477-86. 1995